Andrology & Gynecology: Current ResearchISSN: 2327-4360

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Discovery of a New Anti Androgen Compound

Discovery of a New Anti Androgen Compound

Androgen receptor inhibitors reduce or eliminate symptoms of prostate cancer by inhibiting Androgen receptors. The main advantage of this new compound is that it does not block any other receptors except androgen, and therefore it is very specific. Also another advantage of it in terms of its mechanism of inhibition is that its inhibition efficacy is about 90%, and therefore it would be a very efficient anti-cancer drug for prostate cancer and related diseases. Also when compared to other anti-Androgen drugs, this drug has a different and better enzalutamide activity. 

Special Features

Full Text

View

Track Your Manuscript

Share This Page

Media Partners

Associations